Maven Pharma acquires its first A.I.C., consolidating an already rich catalog of nutraceuticals and medical devices. As a result, Zindel, based on azithromycin dihydrate, becomes part of the Maven Pharma family.

Thanks to continuous efforts and steadily growing revenues, Maven Pharma significantly expands its medical information network, managing to be present in most of the national territory.